Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): Sale of 2,140 MGX shares, $2.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Sale | 2,140 | $2.5K |
| Jun 10, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Sale | 3,737 | $4.9K |
| Apr 3, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Grant/Award | 46,000 | n/a |
| Mar 9, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Gift | 228,462 | n/a |
| Dec 8, 2025 | Metagenomi, Inc. (MGX) | Sale | 1,602 | $2.8K |
| Dec 2, 2025 | Metagenomi, Inc. (MGX) | Sale | 1,602 | $2.9K |
| Jun 9, 2025 | Metagenomi, Inc. (MGX) | Sale | 6,390 | $11.2K |
| Apr 3, 2025 | Metagenomi, Inc. (MGX) | Grant/Award | 23,000 | n/a |
| Apr 4, 2024 | Metagenomi, Inc. (MGX) | Grant/Award | 70,471 | n/a |